Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
Glyphosate Litigation Facts
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
    • Filings and Rulings
  • Resources
  • Media Center
    • Media Statements
    • In The News
  1. Home
  2. In The News
  3. The Crazy Verdicts Against Bayer/Monsanto in the Roundup Litigation

The Crazy Verdicts Against Bayer/Monsanto in the Roundup Litigation

May 16, 2019 in In The News

Reason | By David Bernstein

On Monday, a California jury ruled against Monsanto in a case alleged that the herbicide Roundup caused a couple’s non-Hodgkin’s lymphoma. The jury awarded $55 million in compensatory damages, and an additional $2 billion in punitive damages. This was Monsanto’s third straight loss before a jury in a Roundup case.

To say that these verdicts are  not justified by the scientific evidence would be a massive understatement. Every regulatory body in the world that has studied Roundup has declared that it’s safe and that it’s unlikely that it’s a carcinogen. The only partial exception is that the International Agency for Research on Cancer has declared that the active ingredient in Roundup is a probable carcinogen based on animal studies–but at an undetermined dose through undetermined means of exposure. Regulatory agencies that have revisited Roundup’s safety in the wake of the IARC report have reaffirmed its safety, in part based on new studies not considered by the IARC.

Click here to read more

January 2, 2020
Science
SHARE
  • Email
  • Twitter
  • Facebook
  • Google +
  • Pinterest
  • Tumblr
  • Linkedin
  • Vkontakte
  • WhatsApp
Category
  • Filings and Rulings
  • Five-Point Plan
  • In The News
  • Media Statements
  • Resources
    • Documents
    • Infographics
  • Uncategorized
Tags
Ads alesi Benefits carson ferro five-point plan Hardeman Infographics JCCP Johnson MDL Ninth Circuit Pilliod Prop 65 Regulators Roundup Science Settlement Shelton St. Louis City Supreme Court of California

Five-Point Plan to address potential future Roundup™ claims

Bayer today provided an update on its five-point plan to address future Roundup™ litigation risk after its May 27th decision to withdraw from the national class process. The company is now in more control of important aspects of the risk mitigation process and has sketched out two basic scenarios going forward to provide a path to closure of this litigation. The first scenario is based on obtaining a favorable decision by the United States Supreme Court on a cross-cutting issue like federal preemption which would effectively and largely end the U.S. Roundup™ litigation. The second scenario assumes that the Supreme Court either declines to hear the Hardeman case or issues a ruling in favor of plaintiff – in that case the company would activate its own claims administration program.

Read about the five-point plan here.

Copyright © 2021, All Rights Reserved
Imprint
Privacy Statement

This site was prepared by the Bayer Group for educational purposes only.
For more information on glyphosate herbicides, visit: https://www.bayer.com/en/glyphosate-roundup.aspx.

Copyright © 2019, All Rights Reserved
  • Five-Point Plan
  • Settlement Overview
  • Litigation Overview
  • Resources
  • Media Center